Logo image of BNOR.OL

BLUENORD ASA (BNOR.OL) Stock Fundamental Analysis

OSL:BNOR - Euronext Oslo - NO0010379266 - Common Stock - Currency: NOK

590  +21 (+3.69%)

Fundamental Rating

3

Overall BNOR gets a fundamental rating of 3 out of 10. We evaluated BNOR against 61 industry peers in the Oil, Gas & Consumable Fuels industry. Both the profitability and financial health of BNOR have multiple concerns. BNOR has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year BNOR has reported negative net income.
In the past year BNOR had a positive cash flow from operations.
In multiple years BNOR reported negative net income over the last 5 years.
Each year in the past 5 years BNOR had a positive operating cash flow.
BNOR.OL Yearly Net Income VS EBIT VS OCF VS FCFBNOR.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

BNOR has a Return On Assets of -2.05%. This is amonst the worse of the industry: BNOR underperforms 83.61% of its industry peers.
BNOR has a Return On Equity of -10.18%. This is amonst the worse of the industry: BNOR underperforms 88.52% of its industry peers.
With a Return On Invested Capital value of 5.67%, BNOR is not doing good in the industry: 63.93% of the companies in the same industry are doing better.
BNOR had an Average Return On Invested Capital over the past 3 years of 9.38%. This is below the industry average of 11.72%.
Industry RankSector Rank
ROA -2.05%
ROE -10.18%
ROIC 5.67%
ROA(3y)0.08%
ROA(5y)-0.18%
ROE(3y)-0.58%
ROE(5y)-1.96%
ROIC(3y)9.38%
ROIC(5y)6.79%
BNOR.OL Yearly ROA, ROE, ROICBNOR.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400

1.3 Margins

Looking at the Operating Margin, with a value of 31.11%, BNOR is in the better half of the industry, outperforming 70.49% of the companies in the same industry.
In the last couple of years the Operating Margin of BNOR has grown nicely.
Looking at the Gross Margin, with a value of 55.79%, BNOR is in the better half of the industry, outperforming 62.30% of the companies in the same industry.
BNOR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 31.11%
PM (TTM) N/A
GM 55.79%
OM growth 3Y7.98%
OM growth 5Y29.98%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.05%
GM growth 5Y2.78%
BNOR.OL Yearly Profit, Operating, Gross MarginsBNOR.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2K -2K 4K -4K

1

2. Health

2.1 Basic Checks

BNOR has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
BNOR has more shares outstanding than it did 1 year ago.
BNOR has more shares outstanding than it did 5 years ago.
BNOR has a worse debt/assets ratio than last year.
BNOR.OL Yearly Shares OutstandingBNOR.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
BNOR.OL Yearly Total Debt VS Total AssetsBNOR.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

The Debt to FCF ratio of BNOR is 18.99, which is on the high side as it means it would take BNOR, 18.99 years of fcf income to pay off all of its debts.
BNOR's Debt to FCF ratio of 18.99 is on the low side compared to the rest of the industry. BNOR is outperformed by 68.85% of its industry peers.
BNOR has a Debt/Equity ratio of 1.64. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of BNOR (1.64) is worse than 83.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.64
Debt/FCF 18.99
Altman-Z N/A
ROIC/WACC0.64
WACC8.89%
BNOR.OL Yearly LT Debt VS Equity VS FCFBNOR.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 1.04 indicates that BNOR should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.04, BNOR is doing worse than 78.69% of the companies in the same industry.
BNOR has a Quick Ratio of 1.04. This is a bad value and indicates that BNOR is not financially healthy enough and could expect problems in meeting its short term obligations.
BNOR has a Quick ratio of 0.93. This is in the lower half of the industry: BNOR underperforms 68.85% of its industry peers.
Industry RankSector Rank
Current Ratio 1.04
Quick Ratio 0.93
BNOR.OL Yearly Current Assets VS Current LiabilitesBNOR.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

4

3. Growth

3.1 Past

The earnings per share for BNOR have decreased strongly by -215.83% in the last year.
The Revenue for BNOR has decreased by -11.64% in the past year. This is quite bad
BNOR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.10% yearly.
EPS 1Y (TTM)-215.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-462.5%
Revenue 1Y (TTM)-11.64%
Revenue growth 3Y7.52%
Revenue growth 5Y16.1%
Sales Q2Q%5.07%

3.2 Future

Based on estimates for the next years, BNOR will show a very strong growth in Earnings Per Share. The EPS will grow by 68.13% on average per year.
Based on estimates for the next years, BNOR will show a quite strong growth in Revenue. The Revenue will grow by 18.64% on average per year.
EPS Next Y402.84%
EPS Next 2Y123.96%
EPS Next 3Y68.13%
EPS Next 5YN/A
Revenue Next Year89.22%
Revenue Next 2Y35.07%
Revenue Next 3Y18.64%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BNOR.OL Yearly Revenue VS EstimatesBNOR.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
BNOR.OL Yearly EPS VS EstimatesBNOR.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -100 -200 -300

4

4. Valuation

4.1 Price/Earnings Ratio

BNOR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 6.74, which indicates a rather cheap valuation of BNOR.
Based on the Price/Forward Earnings ratio, BNOR is valued cheaply inside the industry as 81.97% of the companies are valued more expensively.
BNOR is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.38, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 6.74
BNOR.OL Price Earnings VS Forward Price EarningsBNOR.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BNOR is valued a bit more expensive than 65.57% of the companies in the same industry.
65.57% of the companies in the same industry are cheaper than BNOR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 20.83
EV/EBITDA 7.28
BNOR.OL Per share dataBNOR.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 200

4.3 Compensation for Growth

BNOR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BNOR's earnings are expected to grow with 68.13% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y123.96%
EPS Next 3Y68.13%

0

5. Dividend

5.1 Amount

No dividends for BNOR!.
Industry RankSector Rank
Dividend Yield N/A

BLUENORD ASA

OSL:BNOR (4/25/2025, 7:00:00 PM)

590

+21 (+3.69%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)02-12 2025-02-12/bmo
Earnings (Next)05-07 2025-05-07
Inst Owners35.59%
Inst Owner ChangeN/A
Ins Owners1.02%
Ins Owner ChangeN/A
Market Cap15.63B
Analysts83.08
Price Target779.28 (32.08%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-232%
Min EPS beat(2)-415.9%
Max EPS beat(2)-48.1%
EPS beat(4)0
Avg EPS beat(4)-176.45%
Min EPS beat(4)-415.9%
Max EPS beat(4)-48.1%
EPS beat(8)2
Avg EPS beat(8)-91.35%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-10.47%
Min Revenue beat(2)-11.98%
Max Revenue beat(2)-8.97%
Revenue beat(4)1
Avg Revenue beat(4)-4.6%
Min Revenue beat(4)-11.98%
Max Revenue beat(4)4.82%
Revenue beat(8)4
Avg Revenue beat(8)0.5%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)8.22%
EPS NQ rev (1m)-16.33%
EPS NQ rev (3m)-46.51%
EPS NY rev (1m)-10.27%
EPS NY rev (3m)-22.23%
Revenue NQ rev (1m)-8.59%
Revenue NQ rev (3m)-33.07%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.93%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.74
P/S 2.14
P/FCF 20.83
P/OCF 4.87
P/B 2.16
P/tB 2.74
EV/EBITDA 7.28
EPS(TTM)-28.91
EYN/A
EPS(NY)87.54
Fwd EY14.84%
FCF(TTM)28.33
FCFY4.8%
OCF(TTM)121.05
OCFY20.52%
SpS275.6
BVpS272.93
TBVpS215.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.05%
ROE -10.18%
ROCE 7.36%
ROIC 5.67%
ROICexc 6.19%
ROICexgc 6.54%
OM 31.11%
PM (TTM) N/A
GM 55.79%
FCFM 10.28%
ROA(3y)0.08%
ROA(5y)-0.18%
ROE(3y)-0.58%
ROE(5y)-1.96%
ROIC(3y)9.38%
ROIC(5y)6.79%
ROICexc(3y)10.23%
ROICexc(5y)7.37%
ROICexgc(3y)10.87%
ROICexgc(5y)7.85%
ROCE(3y)12.19%
ROCE(5y)8.82%
ROICexcg growth 3Y15.21%
ROICexcg growth 5Y43.84%
ROICexc growth 3Y15.53%
ROICexc growth 5Y45.83%
OM growth 3Y7.98%
OM growth 5Y29.98%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.05%
GM growth 5Y2.78%
F-Score3
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 1.64
Debt/FCF 18.99
Debt/EBITDA 3.22
Cap/Depr 174.52%
Cap/Sales 33.64%
Interest Coverage 1.87
Cash Conversion 87.17%
Profit Quality N/A
Current Ratio 1.04
Quick Ratio 0.93
Altman-Z N/A
F-Score3
WACC8.89%
ROIC/WACC0.64
Cap/Depr(3y)220.14%
Cap/Depr(5y)197.46%
Cap/Sales(3y)32.67%
Cap/Sales(5y)36.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-215.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-462.5%
EPS Next Y402.84%
EPS Next 2Y123.96%
EPS Next 3Y68.13%
EPS Next 5YN/A
Revenue 1Y (TTM)-11.64%
Revenue growth 3Y7.52%
Revenue growth 5Y16.1%
Sales Q2Q%5.07%
Revenue Next Year89.22%
Revenue Next 2Y35.07%
Revenue Next 3Y18.64%
Revenue Next 5YN/A
EBIT growth 1Y-31.46%
EBIT growth 3Y16.1%
EBIT growth 5Y50.9%
EBIT Next Year296.26%
EBIT Next 3Y57.45%
EBIT Next 5YN/A
FCF growth 1Y218.17%
FCF growth 3YN/A
FCF growth 5Y-14.92%
OCF growth 1Y23.45%
OCF growth 3Y84.65%
OCF growth 5Y4.46%